Aurinia Pharmaceuticals AUPH Operating Lease Liability - Undiscounted Excess Amount
Operating Lease Liability - Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's operating lease liability - undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's operating lease liability - undiscounted excess amount?
- Aurinia Pharmaceuticals (AUPH) reported operating lease liability - undiscounted excess amount of $362K in Q1 2026.
- How has Aurinia Pharmaceuticals's operating lease liability - undiscounted excess amount changed year-over-year?
- Aurinia Pharmaceuticals's operating lease liability - undiscounted excess amount decreased by 69.1% year-over-year, from $1.17M to $362K.
- What does operating lease liability - undiscounted excess amount mean?
- This represents the difference between the total undiscounted future lease payments and the present value of those payments recorded on the balance sheet. It effectively quantifies the interest component embedded within operating lease obligations. It is a measure of the financing cost inherent in the lease portfolio.